Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aminaftone for secondary Raynaud's phenomenon in systemic sclerosis (VASC-1)
2008-004048-35Phase 3Completed
- Sponsor
- Laboratori Baldacci
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Raynaud disease and systemic sclerosis (SSc) comparing Aminaftone with Placebo (2 arms). Started Mar 2009; status: completed.
02
Drugs
aminaphthone
03
Conditions
Raynaud diseasesystemic sclerosis (SSc)
Beyond the preview
Go deeper on 2008-004048-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004048-35.